At this time there are no interruptions in our ability to manufacture and supply product. Our clinical team has instituted virtual video trainings for new pump and CGM customers to ensure continuity of service. Please click here for more information.
Today, we look forward to welcoming Companion Medical, makers of the only FDA-cleared smart insulin pen system paired with an integrated diabetes management app, to the Medtronic family. The InPen system automatically records insulin doses, tracks active insulin, and recommends mealtime & correction doses based on a bolus calculator which helps simplify diabetes management*. Listen to this video message from Diabetes Group President Sean Salmon on his vision for simplifying diabetes management for people wherever they are in their journey.
Our vision for the future is to build upon the success of the InPen system by combining it with our intelligent algorithms to deliver proactive and personalized dosing advice. This smart CGM and pen system can help people think less about diabetes and enable them to live life with more freedom, on their own terms**.
We continue to make enhancements to our CGM platform to ensure a seamless experience for our customers regardless of how insulin is delivered. As a trusted partner, our goal is to offer consistent support whether an individual wants to stay on multiple daily injections, transition to automated insulin delivery or take a break from their pump.
Today, there are many people throughout the US, who benefit from the InPen system. We are inspired by these stories and want to share one from Kris Drewery, who has been living with diabetes for 18 years and is enjoying the confidence from the information he gets from the InPen system.
We are excited to partner with the team at Companion Medical and look forward to welcoming them to our family, once the acquisition has closed.
As always, we are grateful for the countless people living with diabetes around the world, who choose Medtronic to support them through their journey.
If you’re currently using the InPen system, you should continue to contact Companion Medical for any support or product needs. Companion Medical can be reached directly at 844-843-7903.
*User interaction, compatible device and proper device pairing and settings required.
**IMPORTANT: The Insights offered by InPen reports are intended to supplement, not replace, medical expertise in the self-administration of insulin for the treatment of diabetes. The report provides information that can be used to identify trends to inform treatment decisions. Reports are not intended to produce medical advice and should not be relied upon for such purpose.
IMPORTANT: The calculated dose is a suggestion. You decide whether to follow the suggestion or rely on your own judgment. The dose calculator cannot account for other factors like activity, illness, alcohol use, etc.
WARNING: Using the Dose Calculator with incorrect Therapy Settings or without all of your recent insulin logged may result in unsafe recommendations, which could lead to severe hyperglycemia, hypoglycemia, or injury.
IMPORTANT SAFETY INFORMATION
The InPen requires a prescription. It is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data.
For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.
Amanda Griswold started working for Medtronic in 2005, after graduating with a degree in Journalism. She’s held a variety of roles including sales, professional relations and marketing. During this time she also obtained her MBA.
Amanda became personally involved with diabetes when she met her husband, who has type 1 diabetes, in 2008. They have a unique story about how they met, which you can read about on the LOOP blog. Since she knows how diabetes affects someone, she’s passionate about making life easier while living with diabetes, from products on the market to customer service.
Amanda enjoys spending time with her husband and three young children.